Viewing Study NCT04912466


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2025-12-28 @ 7:33 AM
Study NCT ID: NCT04912466
Status: COMPLETED
Last Update Posted: 2023-09-06
First Post: 2021-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors.
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module